KLC
NPCE icon

Kent Lake Capital’s Neuropace NPCE Stock Holding History

Kent Lake Capital’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$8.65M Buy
1,144,254
+500,625
+78% +$5.05M 3.9% 8
2024
Q1 		$8.5M Sell
643,629
-27,317
-4% -$390K 3.71% 9
2023
Q4 		$6.92M Buy
670,946
+96,529
+17% +$770K 2.67% 17
2023
Q3 		$5.59M Buy
574,417
+425,212
+285% +$2.49M 2.15% 22
2023
Q2 		$670K Buy
149,205
+21,529
+17% +$97.4K 0.31% 43
2023
Q1 		$592K Buy
+127,676
New +$489K 0.4% 30

Other funds holding NPCE

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Kent Lake Capital's NPCE Position: Q2 2024 in Review

Kent Lake Capital increased its Neuropace (NPCE) stake by 78% in Q2 2024, buying an estimated $5.05M and bringing the position to 1,144,254 shares worth $8.65M. The position accounts for 3.9% of the portfolio, ranked #8.

Kent Lake Capital first reported a position in NPCE in Q1 2023 and has held it in 6 quarters since. 51 funds tracked by Wall St. Rank hold NPCE as of Q2 2024.

  • Kent Lake Capital held 1,144,254 shares of Neuropace worth $8.65M as of Q2 2024.
  • Kent Lake Capital bought 500,625 Neuropace shares in Q2 2024, an estimated $5.05M.
  • Neuropace made up 3.9% of Kent Lake Capital's portfolio in Q2 2024, its #8 holding.
  • Kent Lake Capital first reported a position in Neuropace in Q1 2023 and has held it in 6 quarters since.
  • 51 funds tracked by Wall St. Rank held Neuropace as of Q2 2024.

Based on Kent Lake Capital's 13F filing for Q2 2024, filed 14 Aug 2024.